Nuvectis Pharma (NVCT) stock Forecast for 2022 – 2026
Last update: December 3, 2022 (06:25)Sector: Healthcare
The share price of Nuvectis Pharma, Inc. (NVCT) now
What analysts predict: $20.67
52-week high/low: $20.92 / $3.08
50/200 Day Moving Average: $7.14 / $9.41
This figure corresponds to the average price over the previous 50/200 days. For Nuvectis Pharma stocks, the 50-day moving average is the support level today.
For Nuvectis Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2022, 2023, 2024, 2025, 2026. How much will one Nuvectis Pharma share be worth in 2022 - 2026?
When should I take profit in Nuvectis Pharma stock? When should I record a loss on Nuvectis Pharma stock? What are analysts' forecasts for Nuvectis Pharma stock? What is the future of Nuvectis Pharma stock? We forecast Nuvectis Pharma stock performance using neural networks based on historical data on Nuvectis Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Nuvectis Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Nuvectis Pharma shares. This happens once a day.
Historical and forecast chart of Nuvectis Pharma stock
The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Nuvectis Pharma stock price can be found in the table below.
Long-term forecasts by years.
Nuvectis Pharma daily forecast for a month
Nuvectis Pharma Daily Price Targets
Nuvectis Pharma Stock Forecast 12-05-2022.
Forecast target price for 12-05-2022: $7.86.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.473%.
Pessimistic target level: 7.74
Optimistic target level: 8.19
Nuvectis Pharma Stock Forecast 12-06-2022.
Forecast target price for 12-06-2022: $8.00.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 7.805%.
Pessimistic target level: 7.65
Optimistic target level: 8.30
Nuvectis Pharma Stock Forecast 12-07-2022.
Forecast target price for 12-07-2022: $7.65.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.219%.
Pessimistic target level: 7.41
Optimistic target level: 7.90
Nuvectis Pharma Stock Forecast 12-08-2022.
Forecast target price for 12-08-2022: $7.75.
Positive dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.360%.
Pessimistic target level: 7.47
Optimistic target level: 7.89
Nuvectis Pharma Stock Forecast 12-09-2022.
Forecast target price for 12-09-2022: $7.55.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 6.714%.
Pessimistic target level: 7.30
Optimistic target level: 7.83
Nuvectis Pharma Stock Forecast 12-10-2022.
Forecast target price for 12-10-2022: $7.35.
Negative dynamics for Nuvectis Pharma shares will prevail with possible volatility of 5.977%.
Pessimistic target level: 7.07
Optimistic target level: 7.52
NVCT (NVCT) Monthly Stock Prediction for 2022
Nuvectis Pharma forecast for this year
Nuvectis Pharma Stock Prediction for Dec 2022
An downtrend is forecast for this month with an optimal target price of $6.6646. Pessimistic: $6.22. Optimistic: $7.57
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2023
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2024
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2025
Nuvectis Pharma (NVCT) Monthly Stock Prediction for 2026
Nuvectis Pharma information and performance
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, UNITED STATES
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.